Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats

BACKGROUND: Glucagon-like peptide 1 (GLP-1) analogs and dipeptidyl peptidase-4 (DPP4) inhibitors are a newer class of antidiabetics named as incretin-based therapy. In addition to the homeostatic control of glucose, the incretin-based therapy has shown beneficial effects on the cardiovascular system...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaoyan, Huang, Chin-hu, Lao, Julie, Pocai, Alessandro, Forrest, Gail, Price, Olga, Roy, Sophie, Kelley, David E, Sullivan, Kathleen A, Forrest, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476171/
https://www.ncbi.nlm.nih.gov/pubmed/25888997
http://dx.doi.org/10.1186/s12933-015-0194-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476171/
https://www.ncbi.nlm.nih.gov/pubmed/25888997
http://dx.doi.org/10.1186/s12933-015-0194-3

Ejemplares similares